Moore Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-65,000
Closed -$5.58M 527
2022
Q4
$5.58M Sell
65,000
-534,860
-89% -$42.4M 0.13% 137
2022
Q3
$37M Buy
599,860
+399,111
+199% +$25.2M 0.87% 20
2022
Q2
$12.4M Sell
200,749
-57,359
-22% -$3.55M 0.33% 57
2022
Q1
$15.3M Buy
+258,108
New +$16.5M 0.39% 43
2021
Q2
Sell
-411,628
Closed -$26.6M 848
2021
Q1
$26.6M Buy
+411,628
New +$26.5M 0.34% 52
2020
Q2
Sell
-340,000
Closed -$25.4M 268
2020
Q1
$25.4M Buy
+340,000
New +$23.5M 1.05% 23
2016
Q1
Sell
-20,493
Closed -$2.07M 274
2015
Q4
$2.07M Buy
+20,493
New +$2.13M 0.06% 217
2015
Q3
Sell
-19,142
Closed -$2.24M 334
2015
Q2
$2.24M Sell
19,142
-25,247
-57% -$2.76M 0.05% 302
2015
Q1
$4.36M Buy
+44,389
New +$4.51M 0.1% 180
2014
Q4
Sell
-11,734
Closed -$1.21M 340
2014
Q3
$1.25M Buy
+11,734
New +$1.15M 0.03% 313
2014
Q2
Sell
-2,239,590
Closed -$159M 507
2014
Q1
$159M Buy
2,239,590
+1,939,590
+647% +$152M 3.24% 3
2013
Q4
$22.5M Buy
+300,000
New +$20.9M 0.35% 56
2013
Q3
Sell
-300,000
Closed -$15.4M 383
2013
Q2
$15.4M Buy
+300,000
New +$15.6M 0.37% 56

Other funds holding GILD

Moore Capital Management's GILD Position: Q1 2023 in Review

Moore Capital Management sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 65,000 shares — an estimated $5.58M sold.

Moore Capital Management first reported a position in GILD in Q2 2013 and held it in 13 quarters. The position peaked at $159M in Q1 2014. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Moore Capital Management reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Moore Capital Management sold 65,000 Gilead Sciences shares in Q1 2023, an estimated $5.58M.
  • Moore Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 13 quarters.
  • Moore Capital Management's Gilead Sciences position peaked at $159M in Q1 2014.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Moore Capital Management's 13F filing for Q1 2023, filed 15 May 2023.